James P Allison Selected Research

DNA (Deoxyribonucleic Acid)

10/2016	Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy.
4/2004	CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James P Allison Research Topics

Disease

129	Neoplasms (Cancer) 04/2024 - 11/2001
46	Melanoma (Melanoma, Malignant) 03/2023 - 04/2003
23	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 11/2001
7	Inflammation (Inflammations) 07/2023 - 01/2003
6	Carcinoma (Carcinomatosis) 12/2020 - 04/2003
6	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2001
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2020
4	Disease Progression 01/2021 - 11/2013
4	Breast Neoplasms (Breast Cancer) 12/2016 - 01/2005
3	Infections 01/2023 - 07/2005
3	Colitis 01/2022 - 12/2018
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 11/2019
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 01/2019
3	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 02/2012
3	Experimental Melanoma 03/2014 - 03/2010
3	Testicular Neoplasms (Testicular Cancer) 10/2013 - 10/2011
3	Necrosis 01/2013 - 04/2003
3	Adenocarcinoma 04/2012 - 01/2008
2	Myocarditis (Carditis) 11/2022 - 01/2021
2	Squamous Cell Carcinoma of Head and Neck 04/2022 - 01/2021
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 03/2002
2	Pathologic Complete Response 01/2021 - 09/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 02/2008
2	Virus Diseases (Viral Diseases) 01/2020 - 10/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 04/2007
2	Adenocarcinoma of Lung 10/2017 - 08/2015
2	Brain Neoplasms (Brain Tumor) 01/2017 - 10/2012
2	Exanthema (Rash) 12/2016 - 03/2007
2	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 05/2009
2	Fibrosis (Cirrhosis) 09/2015 - 01/2013
2	Glioma (Gliomas) 10/2012 - 04/2007
1	Nerve Degeneration 07/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2023
1	Enterocolitis 01/2022

Drug/Important Bio-Agent (IBA)

30	AntigensIBA 11/2022 - 01/2003
29	IpilimumabIBA 01/2023 - 03/2007
22	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2014
17	AntibodiesIBA 01/2020 - 04/2003
15	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2012
13	Monoclonal AntibodiesIBA 11/2014 - 02/2005
9	NivolumabIBA 03/2023 - 04/2016
9	CTLA-4 AntigenIBA 01/2022 - 04/2003
8	LigandsIBA 01/2019 - 01/2003
8	VaccinesIBA 11/2014 - 04/2003
7	Proteins (Proteins, Gene)FDA Link 12/2023 - 04/2004
7	CytokinesIBA 01/2020 - 05/2010
7	Neoplasm Antigens (Tumor Antigens)IBA 12/2016 - 03/2008
7	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2011 - 04/2003
6	Peptides (Polypeptides)IBA 09/2015 - 03/2002
6	EpitopesIBA 11/2014 - 01/2006
5	Immunoglobulin G (IgG)IBA 01/2019 - 01/2005
4	AndrogensIBA 04/2024 - 01/2003
4	Interleukin-6 (Interleukin 6)IBA 07/2023 - 01/2016
4	Cancer VaccinesIBA 10/2009 - 04/2003
3	tremelimumabIBA 11/2021 - 01/2019
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2021 - 10/2016
3	AutoantigensIBA 01/2008 - 07/2003
2	Interferon Type IIBA 07/2023 - 03/2014
2	relatlimabIBA 03/2023 - 11/2022
2	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2020
2	sipuleucel-T (APC8015)FDA Link 01/2021 - 10/2011
2	Gemcitabine FDA Link 01/2021 - 06/2014
2	AutoantibodiesIBA 10/2019 - 11/2013
2	InterferonsIBA 01/2017 - 10/2012
2	DNA (Deoxyribonucleic Acid)IBA 10/2016 - 04/2004
2	pembrolizumabIBA 04/2016 - 01/2016
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 10/2015 - 08/2011
2	Oncogene Proteins (Oncogene Protein)IBA 09/2015 - 08/2011
2	Protein Subunit VaccinesIBA 09/2015 - 11/2014
2	Mutant Proteins (Protein, Mutant)IBA 11/2014 - 02/2012
2	Therapeutic UsesIBA 03/2014 - 08/2009
2	EnzymesIBA 10/2013 - 08/2011
2	flt3 ligand protein (flt3 ligand)IBA 10/2012 - 10/2009
2	Interleukin-15 (Interleukin 15)IBA 06/2012 - 04/2012
2	Monophenol Monooxygenase (Tyrosinase)IBA 08/2011 - 04/2004
2	Differentiation AntigensIBA 04/2004 - 04/2003
1	Clodronic Acid (Clodronate)IBA 04/2024
1	Dextrans (Dextran)FDA Link 01/2023
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Myosins (Myosin)IBA 11/2022
1	sitravatinibIBA 01/2022
1	Dietary Fiber FDA Link 12/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021

Therapy/Procedure

79	Therapeutics 04/2024 - 11/2001
57	Immunotherapy 12/2023 - 07/2002
5	Cryosurgery 11/2021 - 01/2012
5	Radiotherapy 01/2021 - 03/2012
4	Castration 04/2024 - 01/2020
4	Drug Therapy (Chemotherapy) 01/2023 - 10/2016
3	Neoadjuvant Therapy 07/2023 - 12/2020
3	Aftercare (After-Treatment) 01/2020 - 01/2005
2	Stem Cell Transplantation 10/2021 - 01/2018
2	Fecal Microbiota Transplantation 01/2019 - 12/2018
2	Immunomodulation 01/2017 - 08/2013
2	Precision Medicine 01/2017 - 01/2016
2	Investigational Therapies (Experimental Therapy) 09/2007 - 11/2001
1	Biological Therapy 12/2023
1	Transplantation 01/2023